MRK: Sac-TMT Gets FDA Breakthrough Therapy Designation For EGFR-mutated Advanced Or Metastatic NSCLC
Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...
Cure Today12d
Radiotherapy and EGFR-TKIs May Improve Treatment Outcomes in Lung Cancer
CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...
BioWorld12d
NMPA clears Alpha’s oral EGFR-TKI for NSCLC with brain metastases
China’s drug regulator approved Alpha Biopharma Ltd.’s EGFR tyrosine kinase inhibitor (TKI), Zorifer (zorifertinib hydrochloride tablets; AZD-3759), as a first-line treatment for EGFR-mutated ...
EurekAlert!27d
Discovery of rapid COVID-19 replication mechanism and expanded treatment options
Dr. Kim’s team revealed that once COVID-19 invades human cells, it quickly modifies the structure and function ... Using FDA-approved EGFR inhibitors, such as vandetanib and dacomitinib, the ...
Nature12y
Activation of ERBB Receptors
EGFR has been ... A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in ...
Discovery of rapid COVID-19 replication mechanism could expand treatment options
Dr. Kim's team revealed that once COVID-19 invades human cells, it quickly modifies the structure and function ... Using ...
Nasdaq15d
CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC
Johnson & Johnson JNJ announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended approving the combination of its intravenously administered EGFR/MET ...